VAERS reports by lot

Moderna COVID-19 lot AS7167B: VAERS reports

84 VAERS reports list lot AS7167B as a Moderna COVID-19 vaccine, received between 2022-10-31 and 2024-04-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
84
Reports
15%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5727%
Cardiac / Cardiovascular3316%
Respiratory2713%
Musculoskeletal2210%
Injection-site / Local reaction2110%
Gastrointestinal2010%
Neurological157%
Allergic / Anaphylactic63%
Thrombotic / Hematological52%
Dermatological (non-injection-site)21%
Autoimmune / Immune-mediated10%
Psychiatric / Neuropsychiatric10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey12
North Carolina6
Kansas6
Washington4
Missouri4
Michigan4
Pennsylvania3
Ohio3
Arkansas3
California3
Iowa2
Nebraska2

Reports by month received

2022-101
2022-1111
2022-1225
2023-0114
2023-0211
2023-035
2023-044
2023-054
2023-064
2023-101
2023-111
2023-122
2024-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.